Literature DB >> 19415423

Migraine prophylaxis: key points for the practising clinician.

F Moschiano1, D D'Amico, Gennaro Bussone.   

Abstract

Migraine is a significant burden on individuals and society. Patients with most severe forms require preventive treatments, whose aim is to reduce the frequency and severity of attacks and consequently the overall impact of migraine. Although various medications are available for migraine prophylaxis, only a minority of migraineurs receive these drugs. This brief paper summarizes the most important indications for starting migraine prophylaxis, and provides an overview of the salient characteristics of available preventive drugs, to guide the choice of the most appropriate medication for a given patient.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19415423     DOI: 10.1007/s10072-009-0055-5

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  2 in total

1.  Efficacy of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in the Preventative Treatment of Episodic Migraine in Adults.

Authors:  T Dorosch; C A Ganzer; M Lin; A Seifan
Journal:  Curr Pain Headache Rep       Date:  2019-09-12

2.  Patient outcome in migraine prophylaxis: the role of psychopharmacological agents.

Authors:  Maurizio Pompili; Gianluca Serafini; Marco Innamorati; Giulia Serra; Giovanni Dominici; Juliana Fortes-Lindau; Monica Pastina; Ludovica Telesforo; David Lester; Paolo Girardi; Roberto Tatarelli; Paolo Martelletti
Journal:  Patient Relat Outcome Meas       Date:  2010-09-17
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.